All studies
AuthorisedTherapeutic exploratory (Phase II)Interventional

PITALC. Pilot study on the effect of PITAC (Pressurized IntraThoracic Aerosol Chemotherapy) by videothoracoscopy in patients with malignant pleural effusion in the light of the results of a retrospective historical cohort treated with talc pleurodesis by videothoracoscopy

When cancer spreads to the lining of the lungs, fluid can gather in the chest space. This is called a malignant pleural effusion, and it often causes breathlessness and chest discomfort. The usual treatment involves draining the fluid and using sterile talc powder to stick the lung layers together. This study tests an alternative technique called PITAC (Pressurised IntraThoracic Aerosol Chemotherapy). During a keyhole operation, surgeons spray two chemotherapy medicines (cisplatin and doxorubicin) directly into the chest space as a fine mist. Researchers want to see if this mist treatment stops fluid from building up again after one month. They will also measure how safe the procedure is, how it affects breathing, and how it impacts patients' quality of life over a full 12-month period.

At a glance

Status
Authorised
Phase
Therapeutic exploratory (Phase II)
Sponsor
Hospices Civils De Lyon
Enrolment target
20
Start
16 Jul 2026

What is this study about?

The lungs are surrounded by a thin, double-layered lining called the pleura. In some people with cancer, fluid can gather between these two layers. This build-up is called a malignant pleural effusion. As the fluid collects, it squashes the lung, making it harder to breathe and causing symptoms like a dry cough, chest tightness, or fatigue.

The usual treatment is to drain the fluid and apply a sterile medical talc inside the chest to seal the space shut. In this study, doctors are exploring a newer method called PITAC. During a short keyhole operation, surgeons use a special spray device to turn liquid chemotherapy drugs into a fine mist inside the chest cavity.

The idea behind using a spray is that it coats the entire lining of the chest evenly. Because the medicine is applied directly where the cancer cells are, it may work well against the fluid build-up while causing fewer body-wide side effects than standard chemotherapy given through a vein.

The main aim of the trial is to see how many patients remain free from fluid build-up one month after surgery. The research team will also follow participants for a year to track their breathing, their general wellbeing, and any side effects.

Key takeaways

  • Tests a chemotherapy mist (PITAC) sprayed directly into the chest using keyhole surgery.
  • Aimed at adults with fluid around the lungs caused by cancer.
  • Checks if the spray stops fluid returning better than standard treatments after 1 month.
  • Follows participants for 12 months with scans, breathlessness checks, and quality-of-life questionnaires.
  • Taking part is completely voluntary and will not compromise your normal healthcare.

Who may be eligible?

This trial is open to adults aged 18 and over who have fluid collecting around their lungs due to cancer (neoplastic pleural effusion). Men and women may both be able to join.

Because the treatment is delivered through keyhole chest surgery, you must be well enough to have a general anaesthetic and a minor operation.

Your cancer care team will carry out health checks, including blood tests and heart or kidney checks, to make sure it is safe for you to receive the chemotherapy medicines used in the trial.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I have been diagnosed with cancer that has caused fluid around my lung.
  3. I am well enough to have a keyhole procedure under general anaesthetic.
  4. My kidneys, liver, and blood counts are suitable for chemotherapy medicines.
Answer every question to see your result.

What does participation involve?

If you take part, you will have a keyhole procedure called a videothoracoscopy under general anaesthetic. The surgeon will drain the fluid from your chest and deliver the chemotherapy spray (cisplatin and doxorubicin). You will then recover in hospital for a short time before going home.

After leaving the hospital, you will have follow-up visits with the research team. At one month, you will have a chest X-ray and an ultrasound to see if any fluid has returned. You will also have check-ups at 3, 6, and 12 months. These visits involve simple questionnaires about your breathing and quality of life, along with a CT scan at 3 months to monitor the area. In total, you will be followed for 12 months.

Potential risks and benefits

Taking part may help relieve breathlessness by preventing fluid from building up again, though this cannot be promised. The direct spray may also cause fewer whole-body side effects than standard chemotherapy. However, there are risks to consider. These include standard surgical risks, such as temporary pain, air leaks from the lung, infection, or bleeding. The chemotherapy drugs can also cause side effects affecting the kidneys, liver, or blood cells. An independent safety board monitors the trial at all times. Taking part is completely your choice, and you can leave the study at any time without your normal NHS care being affected.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    France

Common questions

What is PITAC?

PITAC stands for Pressurised IntraThoracic Aerosol Chemotherapy. It is a technique where chemotherapy is sprayed as a fine mist inside the chest during keyhole surgery.

How is this different from normal chemotherapy?

Normal chemotherapy travels through your entire bloodstream. PITAC delivers the medicine directly to the chest lining, which aims to target the problem area while reducing effects on the rest of your body.

Will I have to stay in hospital?

Yes, you will need to stay in hospital for a short time to recover from the keyhole procedure, just as you would with standard fluid-clearing surgery.

What happens if the fluid comes back?

Your medical team will monitor you closely with X-rays and scans. If fluid returns, they will discuss standard treatment options with you to relieve your symptoms.

Can I leave the study if I change my mind?

Yes. You can withdraw from the trial at any time. You do not have to give a reason, and your regular cancer treatment and care will not be affected.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.